N2-Arylsulfonyl-L-argininamides and the pharmaceutically accepta

Details N2-Arylsulfonyl-L-argininamides and the pharmaceutically accepta N2-Arylsulfonyl-L-argininamides and the pharmaceutically accepta

1977-06-07

1978-11-14

Phillips, Delbert R.

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Reduced antigenicity, reduced ability to bind complement, or...

560168, 4242485, 546147, 42424852, 42424851, 546206, 562427, 562428, 546203, 562430, 546204, 546205, 544159, 544 58, 2601125K, 2603067R, 260307FA, 26032633, 2603472, 2603458R, 260518R, 260518A, 260519, 424246, 424258, 424267, 424270, 424272, 424274, 424283, 424285, 424309, 424319, 560 10, 560153, 560121, 560123, 560124, 560125, A61K 3700, C07C10352

Patent

active

041256042

ABSTRACT:
N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof have been found to be effective as pharmaceutical agents for the inhibition and suppression of thrombosis in mammals.

REFERENCES:
patent: 4046876 (1977-09-01), Okamoto et al.

Affiliated with

Also associated with

Rating

N2-Arylsulfonyl-L-argininamides and the pharmaceutically accepta does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N2-Arylsulfonyl-L-argininamides and the pharmaceutically accepta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N2-Arylsulfonyl-L-argininamides and the pharmaceutically accepta will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1301483